Literature DB >> 18936209

Probiotics stimulate liver and plasma protein synthesis in piglets with dextran sulfate-induced colitis and macronutrient restriction.

Scott V Harding1, Keely G Fraser, Linda J Wykes.   

Abstract

Adequate nutrition and probiotics have each been shown to reduce the severity of colitis, but their impact on hepatic and gastrointestinal protein metabolism has not been studied. Our objective was to determine whether maintaining adequate nutrition compared with administering probiotics affected protein synthesis, colon histopathology, and oxidative stress in our macronutrient-restricted piglet model of colitis. Piglets (n = 8/group) receiving dextran sulfate to induce colitis were randomized to 3 treatment groups: macronutrient restricted (MR); macronutrient restricted with VSL #3 probiotics (MRP), or well nourished (WNC). An additional 8 piglets served as healthy references for comparative purposes given the unique nature of the experimental model. A primed, constant infusion of the tracer L-[ring-(2)H(5)]phenylalanine was performed in colitis piglets after 14 d to determine the fractional synthesis rates of proteins in small intestinal mucosa, colon, and liver and of plasma proteins (total protein, fibrinogen, albumin). Colon histopathology and oxidative stress were also assessed. Compared with MR piglets, both WNC and MRP piglets had higher protein synthesis rates in liver and plasma protein pools. However, only adequate nutrition increased protein synthesis in the colon and decreased colitis severity. Whereas probiotics did not stimulate gastrointestinal protein synthesis or reduce colitis severity, a still-unidentified signaling mechanism between the gut and liver seems to be responsible for the probiotic-induced increase in liver protein and plasma protein synthesis. These data underscore the importance of maintaining nutrient intake in pediatric patients with gastrointestinal disease. A strategy for correcting compromised nutrition seems to be more beneficial for reducing damage during colitis than using probiotics only.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18936209     DOI: 10.3945/jn.108.090019

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  6 in total

1.  Colitis, independent of macronutrient intake, compromises bone structure and strength in growing piglets.

Authors:  Photios Vassilyadi; Scott V Harding; Tom J Hazell; Hope A Weiler; Linda J Wykes
Journal:  Pediatr Res       Date:  2016-06-28       Impact factor: 3.756

Review 2.  Malnutrition, poor post-natal growth, intestinal dysbiosis and the developing lung.

Authors:  Mark A Underwood; Satyan Lakshminrusimha; Robin H Steinhorn; Stephen Wedgwood
Journal:  J Perinatol       Date:  2020-10-14       Impact factor: 2.521

Review 3.  Safety assessment of probiotics for human use.

Authors:  Mary Ellen Sanders; Louis M A Akkermans; Dirk Haller; Cathy Hammerman; James Heimbach; Gabriele Hörmannsperger; Geert Huys; Dan D Levy; Femke Lutgendorff; David Mack; Phoukham Phothirath; Gloria Solano-Aguilar; Elaine Vaughan
Journal:  Gut Microbes       Date:  2010-03-04

4.  Experimental colitis and malnutrition differentially affect the metabolism of glutathione and related sulfhydryl metabolites in different tissues.

Authors:  Photios Vassilyadi; Scott V Harding; Evan Nitschmann; Linda J Wykes
Journal:  Eur J Nutr       Date:  2015-07-25       Impact factor: 5.614

5.  Maintaining adequate nutrition, not probiotic administration, prevents growth stunting and maintains skeletal muscle protein synthesis rates in a piglet model of colitis.

Authors:  Scott V Harding; Olasunkanmi A J Adegoke; Keely G Fraser; Errol B Marliss; Stéphanie Chevalier; Scot R Kimball; Leonard S Jefferson; Linda J Wykes
Journal:  Pediatr Res       Date:  2010-03       Impact factor: 3.756

6.  In Vitro Transcriptome Response to a Mixture of Lactobacilli Strains in Intestinal Porcine Epithelial Cell Line.

Authors:  Ionelia Taranu; Daniela Eliza Marin; Cornelia Braicu; Gina Cecilia Pistol; Ionut Sorescu; Lavinia Laura Pruteanu; Ioana Berindan Neagoe; Dan Cristian Vodnar
Journal:  Int J Mol Sci       Date:  2018-06-30       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.